ArthroCare Reaches New 52-Week High (ARTC)

NEW YORK ( TheStreet) -- ArthroCare Corporation (Nasdaq: ARTC) hit a new 52-week high Friday as it is currently trading at $35.77, above its previous 52-week high of $35.56 with 15,900 shares traded as of 9:40 a.m. ET. Average volume has been 178,800 shares over the past 30 days.

ArthroCare has a market cap of $933 million and is part of the health care sector and health services industry. Shares are up 12.9% year to date as of the close of trading on Thursday.

Arthrocare Corporation, a medical device company, develops, manufactures, and markets surgical products primarily based on its minimally invasive patented Coblation technology. The company has a P/E ratio of 33.3, below the average health services industry P/E ratio of 33.6 and above the S&P 500 P/E ratio of 17.

• Practice your ARTC trading strategies and win cash in our stock game.

TheStreet Ratings rates ArthroCare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full ArthroCare Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.